Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Evelo Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 68 | 3 | 46 | −19 |
| Shares | 47.6M | 54.2K | 85.5M | +38.0M (+79.9%) |
| Value | $161.1M | $184.0K | $180.4M | +$19.4M (+12.1%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Evelo Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CVI Holdings, LLC | 2,054,794 | $4.34M | 0.32% |
| Standard Life Aberdeen plc | 342,465 | $716.0K | 0.00% |
| Ergoteles LLC | 304,329 | $642.0K | 0.02% |
| EcoR1 Capital, LLC | 200,417 | $423.0K | 0.01% |
| Qube Research & Technologies Ltd | 30,760 | $65.0K | 0.00% |
| HRT Financial LP | 28,252 | $59.0K | 0.00% |
| Jump Financial, LLC | 26,500 | $56.0K | 0.00% |
| LMR Partners LLP | 10,833 | $23.0K | 0.00% |
Sold out (27)
Institutions that held Evelo Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (3)
Institutions that held Evelo Biosciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 36,221 | $123.0K |
| Susquehanna Fundamental Investments, LLC | 13,078 | $44.0K |
| Amalgamated Financial Corp. | 4,945 | $17.0K |